NSMF and metastatic malignant neoplasm: We further hypothesize that NELF may be aberrantly co-opted by different EMT TFs to drive the reprogramming of gene expression during distinct stages of EMT, and if so, may represent an important therapeutic vulnerability in metastatic cancers in general.